Bio Spectra

Description

ATTITUDE® COMPLETE CARE toothpaste is formulated with fluoride and features a spearmint flavor. This toothpaste incorporates Super Leaves, which are known for their beneficial properties. It is EWG VERIFIED, indicating compliance with strict ingredient safety standards. The product is vegan and is packaged in a 120 g (4.2 oz) tube. The National Product Number (NPN) for this toothpaste is 80104880.

Uses and Indications

This drug is indicated for the prevention and treatment of dental caries. It effectively fights and protects against cavities through its fluoride protection mechanism. Additionally, it provides a protective barrier against acid erosion, thereby safeguarding tooth integrity. The formulation penetrates tooth enamel to assist in the remineralization of weak spots, contributing to overall dental health.

Dosage and Administration

Healthcare professionals are advised to instruct patients to brush their teeth thoroughly for a minimum of one minute, twice daily. This should preferably occur after each meal, or as directed by a dentist.

For children under 6 years of age, it is recommended to use only a pea-sized amount of toothpaste. Caregivers should supervise the brushing process to ensure proper technique and to prevent swallowing of the toothpaste.

Before using this product in children under 2 years of age, consultation with a dentist or healthcare professional is essential to ensure safety and appropriateness of use.

Contraindications

There are no specific contraindications listed for this product. However, in the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a poison control center.

Warnings and Precautions

It is imperative to keep this medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, immediate action is required. Healthcare professionals should advise patients or caregivers to contact a poison control center or seek medical assistance without delay.

Monitoring for potential adverse effects is essential to ensure patient safety. Regular assessments and appropriate laboratory tests may be necessary, depending on the specific medication and patient circumstances.

Side Effects

Patients should be aware of the following warnings associated with the use of this product. It is crucial to keep the product out of reach of children to prevent accidental ingestion. In the event that the product is swallowed, it is imperative to contact a poison control center or seek medical assistance immediately. These precautions are essential to ensure the safety and well-being of patients and to mitigate potential risks associated with accidental exposure.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Bio Spectra (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should use only a pea-sized amount of the product, and supervision is recommended to ensure proper brushing techniques and to prevent swallowing. For children under 2 years of age, it is advised to consult a dentist or healthcare professional prior to use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while using this medication.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, immediate action is crucial. If the substance is swallowed, it is imperative to contact a poison control center or seek medical assistance without delay.

Healthcare professionals should be aware that prompt intervention can significantly influence the outcome of an overdosage situation. Symptoms may vary depending on the specific substance involved, and monitoring for any adverse effects is essential.

Management procedures should include a thorough assessment of the patient's condition, including vital signs and any presenting symptoms. Supportive care may be necessary, and specific treatment protocols should be followed based on the substance ingested and the severity of the overdosage.

In all cases, the guidance of a poison control center can provide critical information for the appropriate management of the situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is crucial to emphasize the importance of immediate action in the event of accidental swallowing. Patients should be instructed to call a poison control center or seek medical assistance right away if this occurs. This information is vital for ensuring patient safety and minimizing potential risks associated with the medication.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, maintaining a temperature range of 15 to 30 °C. Proper storage conditions are crucial to ensure the integrity and efficacy of the product.

Additional Clinical Information

The product is administered via the dental route and is intended to be part of a comprehensive oral health program that includes regular flossing and dental check-ups. Patients are advised to brush their teeth thoroughly for at least one minute twice daily, preferably after each meal, or as directed by a dentist. For children under 6 years of age, only a pea-sized amount should be used, and they should be supervised to ensure proper brushing and to prevent swallowing. Clinicians should consult a dentist or healthcare professional before recommending use in children under 2 years of age. The product should be stored at room temperature, between 15-30 °C.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Bio Spectra, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)